Since SH-SY5Y cells are a model of neuronal aging [13] and neurodegenerative diseases [50,63], one may conclude that NXN downregulation, antagonism or pharmacologic inhibition might be able to combat aging, if it were to occur in vivo. The gene discussed is NXN; the disease is neurodegenerative disease.